Stem Cell & Bone Marrow Transplant

Selected Abstracts

  1. Schiller GL, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Bone marrow transplantation versus high dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. Journal of Clinical Oncology 10:41-46, 1992.
  2. Schiller GJ, Gale RP. Review Article. A critical reappraisal of gastrointestinal complications of allogeneic bone marrow transplantation. Cell Transplantation 1:265-269.
  3. Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE. Hemolysis of transfused group O red blood cells in minor ABO - incompatible unrelated-donor bone marrow transplants in patients receiving cycosporine without posttransplant methotrexate. Blood 79:3076-3085, 1992.
  4. Schiller G, Gale RP. Is there an effective therapy for chronic graft-versus-host disease ? Bone Marrow Transplantation 11-(3):189-192, 1993.
  5. Schiller GJ, Nimer SD, Gajewski JL, Golde DW. Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation. Bone Marrow Transplantation 7:489-491, 1991.
  6. Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. A phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma. Bone Marrow Transplantation 14:131-136, 1994.
  7. Schiller G, Feig S, Territo M, Wolin M, Belin T, Hunt L, Nimer S, Champlin R, Gajewski J. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors. British Journal of Haematology 88:72-78, 1994.
  8. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, Lichtenstein A, Lill M, Hall J, Berenson R, Berenson J. Transplantation of CD 34+ perpheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390-397, 1995.
  9. Mendoza E, Territo M, Schiller G, Lill M, Kunkel L, Wolin M. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplantation 15:299-303, 1995.
  10. Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW. Orthotopic liver transplantation for bone marrow transplant associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transplantation and Surgery 2(3):225-232, 1996.
  11. Wellisch DK, Centeno J, Guzman J, Belin T. Schiller GJ. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia. A long term follow-up study of quality-of-life measures of survivors. Psychosomatics 37:144-154, 1996.
  12. Petz LD, Calhoun L, Yam P, Cecka M, Schiller G, Faitlowioz AR, Herron R, Sayah D, Wallace RB, Belldegrun A. Transfusion-associated graft-versus-host disease in immunocompetent patients. Report of a fatal case associated with transfusion of blood from a second-degree realtive, and a survey of predisposing factors. Transfusion 33:742-750, 1993.
  13. Sidransky E, Schiller G, Younger J, Ginns EI. Erythropoietin in Gaucher patients. Blood 76(10)(Suppl 1):47a, 1990 [Abstract #180].
  14. Gajewski JL, Petz LD, Calhoun L, Ho W, Schiller GJ, Champlin RE. Immune mediated hemolysis followed by massive reactive hemolysis associated with minor ABO incompatible bone marrow transplants from unrelated donors. Blood 76(10)(Sippl 1):198a, 1990 [Abstract #1584].

Publications

  1. Schiller GJ, Berkman S. Hematologic aspects of renal insufficiency. Blood Reviews 3:141-146, 1989.
  2. Schiller GJ, Nimer SD, Gajewski JL, Golde DW. Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation. Bone Marrow Transplantation 7:489-491, 1991.
  3. Schiller GJ, Gale RP. Review Article. A critical reappraisal of gastrointestinal complications of allogeneic bone marrow transplantation. Cell Transplantation 1:265-269, 1992.
  4. Gajewski JL, Petz LD, Celhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE. Hemolysis of transfused group 0 red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplants methotrexate. Blood 79:3076-3085, 1992.
  5. Schiller G, Gale RP. Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplantation 11(3):189-192, 1993.
  6. Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka R, Cameron JF, Dawson MI, Koeffler HP. 9-cis-retinoic acid: Effect on normal and leukemic hematopoiesis in vitro. Blood 81:1009-1016, 1993.
  7. Gresens CJ, Schiller GJ. The importance of communication between transfusion medicine specialist and clinicians. American Journal of Clinical Pathology 103(4)(Suppl 1): S3-S8, 1995.
  8. Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transplantation and Surgery 2 (3):225-232, 1996.
  9. Bensinger WI, Buckner CD, Rowley S, Appelbaum FA, Benyunes M, Clift R, Martin P, Demirer T, Shannon-Dorcey K, Lee M, Storb R, Schiller G. Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy. The Journal of The American Society of Hematology Blood 88: 4132-4138, 1996.
  10. Schiller,G was guest Editor of Hematology / Oncology Clinics of North America. Hematopoietic Stem Cell Therapy October 1999.
  11. Schiller G, Wong S, Lowe T, Snead G, Paquette R, Sawyers C, Wolin M, Kunkel L, Ting L, Li G, Territo M: Transplantation of IL-2-mobilized autologous peripheral blood progenitor cells for adults with acute myelogenous leukemia in first remission. Leukemia 15: 757-763, 2001.
  12. Stewart AK, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, Dipersio J, Anderson K, Berenson J. Purging of autologous peripheral blood stem cells using CD34 selection does not improve overall or progression free survival following high dose chemotherapy for multiple myeloma: results of a multi-center randomized controlled trial. Journal of Clinical Oncology 19: 3771-3779; 2001.
  13. Krieger MS, Schiller G, Berenson JR, Stewart K, Noga SJ, Ballester O, Tarantolo S, Stiff P, Kuhn D, Scherzo E, Sing A, Jacobs C, White JM, DiPersio J. Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells. Bone Marrow Transplantation 24 (1):25-8, 1999.
  14. Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, Freytes C, Stadmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyumes M, Jacobs C, Berenson R, DiPersio J, Anderson K, Berenson J. Multicenter phase III trial to evaluate CD34+ selected vs. unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 93(6): 1858-1868, 1999.
  15. Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC: A randomized multicenter trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients. Am J Med 108:282-289, 2000.
  16. Vescio RA, Wu CH, Zheng L, Ma H, Liu J, Stewart AK, Ballester O, Noga SJ, Rugo H, Freytes C, Stadtmauer E, Sahebi F, Tarantolo S, Stiff P, Schiller GJ, White M, Jacobs C, DiPersio J, Anderson KC, Berenson JR. Human herpesvirus 8 (KSHV) contamination of the peripheral blood and autograft products of multiple myeloma patients. Bone Marrow Transplantation 25:153-160, 2000.
  17. Amado RG, Schiller GJ. Non-myeloablative Approaches to the Treatment of Sickle Hemoglobinopathies. Seminars in Oncology 27 s5:82-89, 2000.
  18. Bonavida B, NG CH, Jazirehi A, Schiller G, Mizutani Y. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics (Review). International Journal of Oncology 15:793-802, 1999.
  19. Giralt S, Szydlo R, Goldman J, Biggs J, Veum-Stone J, Briggs JC, Herzig R, Klein JP, McGlave PB, Schiller G, Gale R, Rowlings PA,Horowitz M. Effect of short-term interferon therapy on the outcome of subsequent HLA-indentical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis form the international bone marrow transplant registry. Blood 95:410-415, 2000.
  20. Winston DJ, Antin J, Wolff D, Small T, Miller K, Linker C, Kaizer H, Lazarus H, Peterson FB, Bierer B, Cowan MJ, Ho WG, Wingard J, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplantation 28:187-196; 2001.
  21. Stewart AK, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, Dipersio J, Anderson K, Berenson J. Purging of autologous peripheral blood stem cells using CD34 selection does not improve overall or progression free survival following high dose chemotherapy for multiple myeloma: results of a multi-center randomized controlled trial. Journal of Clinical Oncology 19:3771-3779; 2001.
  22. Matei D, Schiller G. Immune-mediated thrombocytopenia. Proceedings of UCLA Healthcare 6:33-39; 2002.
  23. Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis. 34(12):1648-50; 2002.
  24. Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ; Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 101(7):2476-82; 2003.
  25. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463; 2003.

Return to Index / Studies at UCLA/ Book Chapters

Leukemia / Lymphoma / Cancer - Breast & Lung / Multiple Myeloma

Gary Schiller, M.D., F.A.C.P. / Coll Design © 1996 All rights reserved.